GNLX
Price
$2.54
Change
+$0.09 (+3.67%)
Updated
Jun 5, 04:55 PM (EDT)
Capitalization
94.34M
75 days until earnings call
MLTX
Price
$48.87
Change
-$2.18 (-4.27%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
3.1B
63 days until earnings call
Interact to see
Advertisement

GNLX vs MLTX

Header iconGNLX vs MLTX Comparison
Open Charts GNLX vs MLTXBanner chart's image
Genelux
Price$2.54
Change+$0.09 (+3.67%)
Volume$100
Capitalization94.34M
MoonLake Immunotherapeutics
Price$48.87
Change-$2.18 (-4.27%)
Volume$26.66K
Capitalization3.1B
GNLX vs MLTX Comparison Chart
Loading...
GNLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GNLX vs. MLTX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNLX is a Hold and MLTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (GNLX: $2.45 vs. MLTX: $51.05)
Brand notoriety: GNLX and MLTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GNLX: 130% vs. MLTX: 348%
Market capitalization -- GNLX: $92.45M vs. MLTX: $3.24B
GNLX [@Biotechnology] is valued at $92.45M. MLTX’s [@Biotechnology] market capitalization is $3.24B. The market cap for tickers in the [@Biotechnology] industry ranges from $318.09B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNLX’s FA Score shows that 0 FA rating(s) are green whileMLTX’s FA Score has 0 green FA rating(s).

  • GNLX’s FA Score: 0 green, 5 red.
  • MLTX’s FA Score: 0 green, 5 red.
According to our system of comparison, MLTX is a better buy in the long-term than GNLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNLX’s TA Score shows that 4 TA indicator(s) are bullish while MLTX’s TA Score has 6 bullish TA indicator(s).

  • GNLX’s TA Score: 4 bullish, 2 bearish.
  • MLTX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both GNLX and MLTX are a good buy in the short-term.

Price Growth

GNLX (@Biotechnology) experienced а 0.00% price change this week, while MLTX (@Biotechnology) price change was +33.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +9.95%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

GNLX is expected to report earnings on Aug 19, 2025.

MLTX is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($3.1B) has a higher market cap than GNLX($94.3M). GNLX YTD gains are higher at: 3.814 vs. MLTX (-5.725). GNLX has higher annual earnings (EBITDA): -28.78M vs. MLTX (-141.71M). MLTX has more cash in the bank: 448M vs. GNLX (35.1M). GNLX has less debt than MLTX: GNLX (1.79M) vs MLTX (2.83M). GNLX (0) and MLTX (0) have equivalent revenues.
GNLXMLTXGNLX / MLTX
Capitalization94.3M3.1B3%
EBITDA-28.78M-141.71M20%
Gain YTD3.814-5.725-67%
P/E RatioN/AN/A-
Revenue00-
Total Cash35.1M448M8%
Total Debt1.79M2.83M63%
TECHNICAL ANALYSIS
Technical Analysis
GNLXMLTX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
67%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
67%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
66%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 9 days ago
73%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
68%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
GNLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RNPEX66.180.35
+0.53%
American Funds New Perspective R4
FGSKX57.18N/A
N/A
Federated Hermes MDT Mid Cap Growth R6
WSCYX19.43N/A
N/A
Macquarie Small Cap Growth Y
BLRCX11.58N/A
N/A
Brookfield Global Listed Real Estate C
MIGWX26.84N/A
N/A
Marsico Growth Institutional

GNLX and

Correlation & Price change

A.I.dvisor tells us that GNLX and CRSP have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GNLX and CRSP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNLX
1D Price
Change %
GNLX100%
-4.67%
CRSP - GNLX
32%
Poorly correlated
+0.03%
SNSE - GNLX
32%
Poorly correlated
+4.14%
BEAM - GNLX
31%
Poorly correlated
+1.60%
CGON - GNLX
31%
Poorly correlated
-0.78%
SYRE - GNLX
30%
Poorly correlated
-0.30%
More

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been loosely correlated with XENE. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if MLTX jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
+5.15%
XENE - MLTX
47%
Loosely correlated
-0.85%
XNCR - MLTX
46%
Loosely correlated
-0.44%
IDYA - MLTX
45%
Loosely correlated
-2.50%
DNLI - MLTX
45%
Loosely correlated
+3.52%
CRNX - MLTX
44%
Loosely correlated
+0.78%
More